Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 3/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 9/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 3/20 | 0.35 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16790748 | 0.88 | ALB (0.42) | ALBFOLH1SIRT1SIRT6MEN1 | |
| SCHEMBL19441321 | 0.85 | SIRT1 (0.34) | ALBFOLH1SIRT1SIRT2MEN1 | |
| SCHEMBL16790733 | 0.75 | ALDH1A1 (0.46) | ALBFOLH1SIRT1SIRT6SIRT2 | |
| SCHEMBL10167182 | 0.75 | EPHX1 (0.50) | ALBFOLH1SIRT1SIRT6SIRT2 | |
| SCHEMBL19069723 | 0.75 | ALB (0.58) | ALBFOLH1SIRT1SIRT6 | |
| SCHEMBL13321836 | 0.74 | FOLH1 (0.50) | ALBFOLH1SIRT1SIRT6SIRT2 | |
| SCHEMBL18477394 | 0.74 | SIRT1 (0.41) | SIRT1SIRT6SIRT2SIRT5 | |
| SCHEMBL20528861 | 0.73 | FOLH1 (0.49) | ALBFOLH1 | |
| SCHEMBL20528860 | 0.73 | FOLH1 (0.49) | ALBFOLH1 | |
| SCHEMBL16790731 | 0.73 | MEN1 (0.46) | ALBFOLH1SIRT1SIRT6MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783571-B2 | Isolation of cysteine containing peptides | MARTIN WARHAM LANCE (US) | 2017-10-10 | — | — | US | disclosed |
| US-20150158905-A1 | Isolation of Cysteine Containing Peptides | MARTIN WARHAM LANCE (US) | 2015-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150158905-A1 | Isolation of Cysteine Containing Peptides | LNPEP, CSTB, CPB1 | ALB 765/4885FOLH1 59/4885SIRT1 4696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.